Physician profile
Amit Arvind Doshi
NPI 1750505582
$19,541.20
in general payments reported to CMS, 2019-2025
18 companies · $991 in 2025
The $991 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,116 · 2020: $3,871 · 2021: $840 · 2022: $1,718 · 2023: $4,104 · 2024: $6,902 · 2025: $991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,563 · Food and Beverage: $2,434.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,562.50 |
| Food and Beverage | $2,434.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $9,562.50 | 2023-2024 | Carto 3 |
| Biotronik INC. | $3,771.03 | 2019-2022 | |
| Abbott Laboratories | $1,553.60 | 2019-2025 | Amplatzer Amulet, Ensite Precision, Ensite |
| Boston Scientific Corporation | $1,422.25 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Access System, Rhythmia Mapping System |
| Biosense Webster, INC. | $1,153.99 | 2019-2025 | Carto 3 |
| Medtronic, INC. | $770.45 | 2021-2025 | Micra, Linq II, Na |
| Medtronic Vascular, INC. | $331.94 | 2019-2020 | |
| Abiomed | $298.11 | 2022 | |
| Atricure, INC. | $245.81 | 2021-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Acutus Medical, INC. | $135.19 | 2020 | |
| Cordis US Corp. | $92.07 | 2025 | |
| Cardiva Medical, INC. | $68.01 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $41.01 | 2023-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $34.66 | 2022-2024 | Eliquis |
| Janssen Pharmaceuticals, INC | $18.93 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $16.09 | 2022 | |
| Amgen INC. | $14.21 | 2025 | Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Doshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.